Creation of a vascular inducing device using mesenchymal stem cells to induce angiogenesis

J Biosci Bioeng. 2021 Oct;132(4):408-416. doi: 10.1016/j.jbiosc.2021.06.012. Epub 2021 Jul 26.

Abstract

Conventional treatments of peripheral vascular disease and coronary artery disease have partial success but are still limited. Methods to deliver angiogenic factors into ischemic areas using gene, protein and cell therapies are faced with difficult issues such a delivery, effective concentration and duration of action. Tissue engineering offers the possibility of creating a functional self-contained three-dimensional (3D) unit that works as a coordinated biological pump that can secrete a whole range of angiogenic factors. We report a tissue engineering approach using decellularized micro-fragments and mesenchymal stem cells (MSCs) to create a vascular inducing device (VID). Proteomic analysis of the decellularized micro-fragments and of the VIDs reveals a large number of extracellular-matrix (ECM) proteins. Moreover, the VIDs were found to transcribe and secrete a whole repertoire of angiogenic factors in a sustained manner. Furthermore, preliminary results of implantation VIDs into non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice indicate formation of vascular network at the site within a week. We propose that those VIDs could serve as a safe, localized, simple and powerful method for the treatment of certain types of vascular diseases.

Keywords: Angiogenesis; Growth factors; Stem cells; Tissue engineering; Vascular diseases.

MeSH terms

  • Animals
  • Mesenchymal Stem Cells*
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Neovascularization, Physiologic
  • Proteomics